Accuray Incorporated (ARAY) Stock Forecast: StockMap's 2-Week Call
ARAY stock forecast: StockMap's model makes no two-week call on Accuray Incorporated after the Nov 19 close: its evidence is split, 2 reasons for and 13 against. Right in 4 of 6 two-week windows on ARAY since Aug 21; by chance, a call on the same dates was right 58% of the time.
Accuray Incorporated last closed at $2.12, -15.20% on the session.
Against the IVW growth benchmark the position is -12.87% over the forecast window.
Accuray Incorporated's market cap is $6.37M as of November 19, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 1 (too close to call).
Where ARAY sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 2 bullish and 13 bearish.
Agreement across those insights is 13%.
44 daily calls for ARAY so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Accuray Incorporated in the 21st percentile on return on equity, where 100 is best.
Accuray Incorporated is classified under Health Care / Health Care Equipment & Supplies.
StockMap tracks Accuray Incorporated as the 132nd largest of the 141 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.
Across that group the current two-week reads are 69 Neutral, 55 Moderate Underperform, 14 Strong Underperform and 3 Moderate Outperform.
On that composite Accuray Incorporated ranks 25th of 141 in the group, against a group median of -0.18.